The Beauty Health Company (SKIN) Stock Forecast
Data as of May 2, 2026Consumer Defensive · Current price $0.85 (+0.14%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Sep 19, 2025 | George Kelly | Roth Capital | $3.50 | +310.4% |
| May 5, 2025 | Susan Anderson | Canaccord Genuity | $1.25 | +46.6% |
| Aug 9, 2024 | Korinne Wolfmeyer | Piper Sandler | $1.00 | +17.2% |
| May 10, 2024 | Korinne Wolfmeyer | Piper Sandler | $2.50 | +193.1% |
| Mar 13, 2024 | Korinne Wolfmeyer | Piper Sandler | $3.00 | +251.7% |
| Mar 13, 2024 | Jonathan Block | Stifel Nicolaus | $4.00 | +369.0% |
Top Analysts Covering SKIN
SKIN vs Sector & Market
| Metric | SKIN | Consumer Defensive Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.55 | 2.41 |
| Analyst Count | 3 | 12 | 18 |
| Target Upside | +52.4% | +1188.5% | +14.9% |
| P/E Ratio | -11.19 | -7.24 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $76M | $77M | $77M | 6 |
| 2026-09-30 | $70M | $71M | $73M | 4 |
| 2026-12-31 | $82M | $83M | $84M | 5 |
| 2027-03-31 | $68M | $69M | $70M | 3 |
| 2027-06-30 | $78M | $79M | $80M | 3 |
| 2027-09-30 | $72M | $73M | $75M | 3 |
| 2027-12-31 | $85M | $86M | $88M | 3 |
| 2028-12-31 | $322M | $322M | $322M | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-0.05 | $-0.03 | $0.01 | 5 |
| 2026-09-30 | $-0.05 | $-0.05 | $-0.05 | 1 |
| 2026-12-31 | $-0.01 | $-0.01 | $-0.01 | 1 |
| 2027-03-31 | $-0.06 | $-0.06 | $-0.05 | 1 |
| 2027-06-30 | $-0.04 | $-0.04 | $-0.03 | 1 |
| 2027-09-30 | $-0.06 | $-0.06 | $-0.06 | 1 |
| 2027-12-31 | $-0.04 | $-0.04 | $-0.03 | 1 |
| 2028-12-31 | $-0.16 | $-0.14 | $-0.12 | 3 |
Frequently Asked Questions
What is the analyst consensus for SKIN?
The consensus among 3 analysts covering The Beauty Health Company (SKIN) is Hold with an average price target of $1.60.
What is the highest price target for SKIN?
The highest price target for SKIN is $4.00, set by Jonathan Block at Stifel Nicolaus on 2024-03-13.
What is the lowest price target for SKIN?
The lowest price target for SKIN is $1.00, set by Korinne Wolfmeyer at Piper Sandler on 2024-08-09.
How many analysts cover SKIN?
3 analysts have issued ratings for The Beauty Health Company in the past 12 months.
Is SKIN a buy or sell right now?
Based on 3 analyst ratings, SKIN has a consensus rating of Hold (3.00/5) with a +52.4% upside to the consensus target of $1.60.
What are the earnings estimates for SKIN?
Analysts estimate SKIN will report EPS of $-0.03 for the period ending 2026-06-30, with revenue estimated at $77M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.